1. Home
  2. DXCM vs WTW Comparison

DXCM vs WTW Comparison

Compare DXCM & WTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • WTW
  • Stock Information
  • Founded
  • DXCM 1999
  • WTW 1828
  • Country
  • DXCM United States
  • WTW United Kingdom
  • Employees
  • DXCM N/A
  • WTW N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • WTW Specialty Insurers
  • Sector
  • DXCM Health Care
  • WTW Finance
  • Exchange
  • DXCM Nasdaq
  • WTW Nasdaq
  • Market Cap
  • DXCM 34.1B
  • WTW 31.0B
  • IPO Year
  • DXCM 2005
  • WTW N/A
  • Fundamental
  • Price
  • DXCM $79.28
  • WTW $314.77
  • Analyst Decision
  • DXCM Strong Buy
  • WTW Strong Buy
  • Analyst Count
  • DXCM 19
  • WTW 9
  • Target Price
  • DXCM $99.89
  • WTW $360.56
  • AVG Volume (30 Days)
  • DXCM 3.2M
  • WTW 711.5K
  • Earning Date
  • DXCM 07-30-2025
  • WTW 07-31-2025
  • Dividend Yield
  • DXCM N/A
  • WTW 1.17%
  • EPS Growth
  • DXCM N/A
  • WTW N/A
  • EPS
  • DXCM 1.43
  • WTW 1.33
  • Revenue
  • DXCM $4,300,800,000.00
  • WTW $9,808,000,000.00
  • Revenue This Year
  • DXCM $16.74
  • WTW N/A
  • Revenue Next Year
  • DXCM $15.42
  • WTW $5.58
  • P/E Ratio
  • DXCM $55.44
  • WTW $237.35
  • Revenue Growth
  • DXCM 11.34
  • WTW 1.26
  • 52 Week Low
  • DXCM $57.52
  • WTW $271.01
  • 52 Week High
  • DXCM $93.25
  • WTW $344.14
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 35.30
  • WTW 57.63
  • Support Level
  • DXCM $83.23
  • WTW $298.43
  • Resistance Level
  • DXCM $89.98
  • WTW $320.18
  • Average True Range (ATR)
  • DXCM 1.91
  • WTW 6.60
  • MACD
  • DXCM -0.54
  • WTW 0.56
  • Stochastic Oscillator
  • DXCM 3.17
  • WTW 75.13

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About WTW Willis Towers Watson Public Limited Company

Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.

Share on Social Networks: